![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Astellas’ Clot Drug Raises Bleeding in Heart Study
Astellas’ Clot Drug Raises Bleeding in Heart Study
August 31, 2011
An experimental anti-clotting drug from Japan’s Astellas increased bleeding two- to four-fold in a mid-stage clinical study of heart patients, raising questions about its role in treating those with acute coronary problems.
Reuters
Reuters
Upcoming Events
-
21Oct